Detalles de la búsqueda
1.
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).
Breast Cancer Res Treat
; 190(2): 265-275, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476645
2.
The possibilities of molecular testing of somatic aberrations in tumor tissue using NGS in routine practice - current situation in the Czech Republic.
Cesk Patol
; 57(3): 147-149, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551562
3.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25877855
4.
Bevacizumab with chemotherapy in patients with KRAS wild-type metastatic colorectal cancer: Czech registry data.
Future Oncol
; 11(2): 225-32, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25591837
5.
Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry.
BMC Gastroenterol
; 14: 53, 2014 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24666582
6.
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.
Int J Radiat Oncol Biol Phys
; 110(4): 1090-1097, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587990
7.
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients.
Cancer Manag Res
; 12: 5365-5372, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32753954
8.
FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
Clin Immunol
; 131(1): 1-10, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19201656
9.
Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.
Oncol Res Treat
; 42(12): 629-635, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31550719
10.
Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
J Med Imaging Radiat Oncol
; 63(6): 829-835, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486267
11.
Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management.
Pathol Oncol Res
; 24(3): 623-630, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28803261
12.
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial.
J Geriatr Oncol
; 9(1): 32-39, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807738
13.
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry.
Target Oncol
; 12(1): 89-95, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27638381
14.
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study.
Clin Colorectal Cancer
; 16(4): 334-342, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28462853
15.
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.
Cancer Chemother Pharmacol
; 80(3): 599-608, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28744667
16.
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
Target Oncol
; 11(3): 383-400, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26706237
17.
Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study.
Target Oncol
; 10(4): 557-63, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25903462
18.
Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry.
Anticancer Res
; 35(6): 3455-61, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26026110
19.
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
J Gastrointest Cancer
; 46(2): 109-17, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25707610
20.
Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancer.
Clin Breast Cancer
; 15(1): 8-15, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25218708